A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family.

[1]  S. Avigad,et al.  A novel germ line p53 mutation in intron 6 in diverse childhood malignancies , 1997, Oncogene.

[2]  V. Rotter,et al.  A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. , 1995, DNA and cell biology.

[3]  C. Felix,et al.  Complex replication error causes p53 mutation in a Li-Fraumeni family. , 1995, Cancer research.

[4]  D. Malkin,et al.  p53 and the Li-Fraumeni syndrome. , 1994, Biochimica et biophysica acta.

[5]  D. Lane,et al.  Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. , 1994, British Journal of Cancer.

[6]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[7]  M. Green,et al.  Allelic variation of reporter gene activation by the HRAS1 minisatellite. , 1993, Genomics.

[8]  J. Serth,et al.  Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene. , 1993, Clinical chemistry.

[9]  R. Reddel,et al.  Germ-line splicing mutation of the p53 gene in a cancer-prone family. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  D. Lane,et al.  Abnormal expression of wild type p53 protein in normal cells of a cancer family patient , 1992, The Lancet.

[11]  S. O’Brien,et al.  Detecting single base substitutions as heteroduplex polymorphisms. , 1992, Genomics.

[12]  T. McDaniel,et al.  Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. , 1992, Cancer research.

[13]  Thierry Soussi,et al.  TP53 tumor suppressor gene: A model for investigating human mutagenesis , 1992, Genes, chromosomes & cancer.

[14]  T. McDaniel,et al.  The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. , 1991, Nucleic acids research.

[15]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[16]  J. Yokota,et al.  Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma. , 1990, Biochemical and biophysical research communications.

[17]  R. Moll,et al.  Heterogeneity of intermediate filament expression in human testicular seminomas. , 1990, Differentiation; research in biological diversity.

[18]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[19]  M. Bar‐eli,et al.  A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation , 1990, British journal of haematology.

[20]  J. Minna,et al.  Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. , 1990, The Journal of clinical investigation.

[21]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[23]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Abraham,et al.  Fluorescent 2'(3')-O-aminoacylnucleosides-acceptor substrates for ribosomal peptidyltransferase+. , 1976, Nucleic acids research.

[25]  A T Look,et al.  Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. , 1994, Oncogene.

[26]  C. Felix,et al.  A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. , 1993, Oncogene.

[27]  P. Guevara,et al.  Rapid recovery of DNA from paraffin-embedded tissue sections for routine polymerase chain reaction analysis , 1993 .

[28]  G. Thomas,et al.  Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. , 1993, Oncogene.

[29]  D. Parkinson,et al.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients , 1985, Nature.